Effect of acute lower respiratory tract infection on pulmonary artery pressure in children with post-tricuspid left-to-right shunt.
Sakshi SachdevaShyam S KothariSaurabh Kumar GuptaSivasubramanian RamakrishnanAnita SaxenaPublished in: Cardiology in the young (2021)
We sought to examine the influence of clinically severe lower respiratory tract infection on pulmonary artery pressure in children having CHD with post-tricuspid left-to-right shunt, as it may have physiological and clinical implications. In a prospective single-centre observational study, 45 children with post-tricuspid left-to-right shunt and clinically severe lower respiratory tract infection were evaluated during the illness and 2 weeks after its resolution. Pulmonary artery systolic pressure was estimated non-invasively using shunt gradient by echocardiography and systolic blood pressure measured non-invasively.Median pulmonary artery systolic pressure during lower respiratory tract infection was only mildly (although statistically significantly) elevated during lower respiratory tract infection [60 (42-74) versus 53 (40-73) mmHg, (p < 0.0001)]. However, clinically significant change in pulmonary artery systolic pressure defined as the increase of >10 mmHg was present in only 9 (20%) patients. In the absence of hypoxia or acidosis, only a small minority (9%, n = 4) showed significant pulmonary artery systolic pressure rise >10 mmHg. In the absence of hypoxia or acidosis, severe lower respiratory tract infection in patients with acyanotic CHD results in only mild elevation of pulmonary artery systolic pressure in most of the patients.
Keyphrases
- pulmonary artery
- respiratory tract
- blood pressure
- pulmonary hypertension
- coronary artery
- pulmonary arterial hypertension
- left ventricular
- heart failure
- end stage renal disease
- young adults
- ejection fraction
- chronic kidney disease
- hypertensive patients
- heart rate
- transcatheter aortic valve replacement
- prognostic factors
- type diabetes
- aortic stenosis
- adipose tissue
- atrial fibrillation
- liver failure
- single molecule
- patient reported outcomes
- acute respiratory distress syndrome
- weight loss